About the Clinical Diabetes and Epidemiology Laboratory
The Clinical Diabetes and Epidemiology group has two main focuses. The first relates to the epidemiology of type 2 diabetes, examining trends in prevalence and incidence of diabetes (predominantly type 2) in Australia as well as the rest of the world. The work in this area, pioneered by Professor Paul Zimmet, has been instrumental in demonstrating the rapid growth of the emerging global diabetes epidemic. The surveys undertaken for this work also provide rich data for interrogating a range of putative and novel risk factors for diabetes and its complications, of which lifestyle factors have been studied extensively and remain an important target. The group also has a specific interest in the impact of diabetes on indigenous populations. The second focus capitalises on the large patient population in our Diabetes Clinic. This facilitates examination of novel treatments, and of observational data on real world responses to therapies.
- Trends in diabetes prevalence and incidence.
- Identifying novel risk factors for type 2 diabetes and its complications at a population level.
- Diabetes and indigenous health.
- Novel therapies for diabetes.